US Stock MarketDetailed Quotes

SGMT Sagimet Biosciences

Watchlist
  • 5.690
  • +0.150+2.71%
Close Nov 29 13:00 ET
  • 5.690
  • 0.0000.00%
Post 13:01 ET
183.19MMarket Cap-4884P/E (TTM)

Sagimet Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-404.49%-19.57M
1.50%-5.63M
12.37%-6.21M
2.96%-23.77M
4.96%-7.08M
37.78%-3.88M
6.81%-5.72M
-51.85%-7.08M
-12.81%-24.49M
-7.45M
Net income from continuing operations
-130.11%-14.62M
-19.65%-8.12M
-0.64%-6.63M
8.60%-27.88M
-13.29%-8.15M
14.92%-6.35M
4.46%-6.79M
24.59%-6.59M
-24.78%-30.5M
---7.2M
Operating gains losses
----
----
----
-33.33%-4K
----
----
----
200.00%2K
-50.00%-3K
----
Other non cash items
5.71%37K
2.94%35K
5.88%36K
6.92%139K
9.09%36K
6.06%35K
6.25%34K
6.25%34K
-2.99%130K
--33K
Change In working capital
-1,123.17%-6.01M
7,485.00%1.48M
85.69%-181K
-123.21%-978K
69.86%-280K
-34.78%587K
-103.39%-20K
-134.63%-1.27M
7,761.82%4.21M
---929K
-Change in prepaid assets
-463.27%-4.31M
-0.97%408K
1,829.73%640K
-166.30%-952K
-610.91%-562K
-532.23%-765K
520.41%412K
-102.39%-37K
404.88%1.44M
--110K
-Change in payables and accrued expense
-219.51%-1.66M
375.51%1.09M
34.45%-782K
-95.88%120K
131.84%320K
31.66%1.39M
-155.85%-396K
-155.33%-1.19M
420.54%2.92M
---1.01M
-Change in other current liabilities
0.00%-37K
38.89%-22K
-11.43%-39K
-6.57%-146K
-11.76%-38K
-8.82%-37K
-71.43%-36K
27.08%-35K
4.86%-137K
---34K
Cash from discontinued investing activities
Operating cash flow
-404.49%-19.57M
1.50%-5.63M
12.37%-6.21M
2.96%-23.77M
4.96%-7.08M
37.78%-3.88M
6.81%-5.72M
-51.85%-7.08M
-12.81%-24.49M
---7.45M
Investing cash flow
Cash flow from continuing investing activities
624K
-687.16%-75.16M
-84.54%3M
139.30%12.58M
-460.93%-19.62M
0
130.88%12.8M
19.4M
-32.01M
5.44M
Net investment purchase and sale
--624K
-687.16%-75.16M
-84.54%3M
139.30%12.58M
-460.93%-19.62M
--0
130.88%12.8M
--19.4M
---32.01M
--5.44M
Cash from discontinued investing activities
Investing cash flow
--624K
-687.16%-75.16M
-84.54%3M
139.30%12.58M
-460.93%-19.62M
--0
130.88%12.8M
--19.4M
---32.01M
--5.44M
Financing cash flow
Cash flow from continuing financing activities
0
97.03%-27K
77,192.65%104.85M
118,136.99%86.17M
0
87.21M
-2,933.33%-910K
-1,233.33%-136K
-100.75%-73K
-55K
Net common stock issuance
--0
--0
--105.75M
--89.68M
--3.52M
--86.16M
--0
--0
--0
--0
Proceeds from stock option exercised by employees
--0
--0
--114K
-50.00%6K
--0
--6K
--0
--0
-93.65%12K
--0
Net other financing activities
--0
97.03%-27K
-648.53%-1.02M
-4,038.82%-3.52M
----
----
---910K
---136K
93.22%-85K
---55K
Cash from discontinued financing activities
Financing cash flow
--0
97.03%-27K
77,192.65%104.85M
118,136.99%86.17M
--0
--87.21M
-2,933.33%-910K
-1,233.33%-136K
-100.75%-73K
---55K
Net cash flow
Beginning cash position
418.47%95.96M
1,332.78%176.78M
47,456.33%75.14M
-99.72%158K
4,466.91%101.84M
314.61%18.51M
-76.31%12.34M
-99.72%158K
-17.42%56.73M
--2.23M
Current changes in cash
-122.73%-18.95M
-1,409.85%-80.82M
734.47%101.64M
232.54%74.98M
-1,188.75%-26.7M
3,830.26%83.33M
112.96%6.17M
361.77%12.18M
-372.58%-56.57M
---2.07M
End cash Position
-24.38%77.01M
418.47%95.96M
1,332.78%176.78M
47,456.33%75.14M
47,456.33%75.14M
4,466.91%101.84M
314.61%18.51M
-76.31%12.34M
-99.72%158K
--158K
Free cash flow
-404.49%-19.57M
1.50%-5.63M
12.37%-6.21M
2.96%-23.77M
4.96%-7.08M
37.78%-3.88M
6.81%-5.72M
-51.85%-7.08M
-12.81%-24.49M
---7.45M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -404.49%-19.57M1.50%-5.63M12.37%-6.21M2.96%-23.77M4.96%-7.08M37.78%-3.88M6.81%-5.72M-51.85%-7.08M-12.81%-24.49M-7.45M
Net income from continuing operations -130.11%-14.62M-19.65%-8.12M-0.64%-6.63M8.60%-27.88M-13.29%-8.15M14.92%-6.35M4.46%-6.79M24.59%-6.59M-24.78%-30.5M---7.2M
Operating gains losses -------------33.33%-4K------------200.00%2K-50.00%-3K----
Other non cash items 5.71%37K2.94%35K5.88%36K6.92%139K9.09%36K6.06%35K6.25%34K6.25%34K-2.99%130K--33K
Change In working capital -1,123.17%-6.01M7,485.00%1.48M85.69%-181K-123.21%-978K69.86%-280K-34.78%587K-103.39%-20K-134.63%-1.27M7,761.82%4.21M---929K
-Change in prepaid assets -463.27%-4.31M-0.97%408K1,829.73%640K-166.30%-952K-610.91%-562K-532.23%-765K520.41%412K-102.39%-37K404.88%1.44M--110K
-Change in payables and accrued expense -219.51%-1.66M375.51%1.09M34.45%-782K-95.88%120K131.84%320K31.66%1.39M-155.85%-396K-155.33%-1.19M420.54%2.92M---1.01M
-Change in other current liabilities 0.00%-37K38.89%-22K-11.43%-39K-6.57%-146K-11.76%-38K-8.82%-37K-71.43%-36K27.08%-35K4.86%-137K---34K
Cash from discontinued investing activities
Operating cash flow -404.49%-19.57M1.50%-5.63M12.37%-6.21M2.96%-23.77M4.96%-7.08M37.78%-3.88M6.81%-5.72M-51.85%-7.08M-12.81%-24.49M---7.45M
Investing cash flow
Cash flow from continuing investing activities 624K-687.16%-75.16M-84.54%3M139.30%12.58M-460.93%-19.62M0130.88%12.8M19.4M-32.01M5.44M
Net investment purchase and sale --624K-687.16%-75.16M-84.54%3M139.30%12.58M-460.93%-19.62M--0130.88%12.8M--19.4M---32.01M--5.44M
Cash from discontinued investing activities
Investing cash flow --624K-687.16%-75.16M-84.54%3M139.30%12.58M-460.93%-19.62M--0130.88%12.8M--19.4M---32.01M--5.44M
Financing cash flow
Cash flow from continuing financing activities 097.03%-27K77,192.65%104.85M118,136.99%86.17M087.21M-2,933.33%-910K-1,233.33%-136K-100.75%-73K-55K
Net common stock issuance --0--0--105.75M--89.68M--3.52M--86.16M--0--0--0--0
Proceeds from stock option exercised by employees --0--0--114K-50.00%6K--0--6K--0--0-93.65%12K--0
Net other financing activities --097.03%-27K-648.53%-1.02M-4,038.82%-3.52M-----------910K---136K93.22%-85K---55K
Cash from discontinued financing activities
Financing cash flow --097.03%-27K77,192.65%104.85M118,136.99%86.17M--0--87.21M-2,933.33%-910K-1,233.33%-136K-100.75%-73K---55K
Net cash flow
Beginning cash position 418.47%95.96M1,332.78%176.78M47,456.33%75.14M-99.72%158K4,466.91%101.84M314.61%18.51M-76.31%12.34M-99.72%158K-17.42%56.73M--2.23M
Current changes in cash -122.73%-18.95M-1,409.85%-80.82M734.47%101.64M232.54%74.98M-1,188.75%-26.7M3,830.26%83.33M112.96%6.17M361.77%12.18M-372.58%-56.57M---2.07M
End cash Position -24.38%77.01M418.47%95.96M1,332.78%176.78M47,456.33%75.14M47,456.33%75.14M4,466.91%101.84M314.61%18.51M-76.31%12.34M-99.72%158K--158K
Free cash flow -404.49%-19.57M1.50%-5.63M12.37%-6.21M2.96%-23.77M4.96%-7.08M37.78%-3.88M6.81%-5.72M-51.85%-7.08M-12.81%-24.49M---7.45M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data